Phase I Clinical Trials CROs
88 published
88 published CROs match Phase I Clinical Trials.
Locations in this set include United States, United Kingdom, India, France, Australia, and Germany.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, Cell Therapy, and Vaccine.
Matching companies
ProtheragenSpecialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.
Proxima Clinical ResearchProxima Clinical Research provides integrated regulatory, clinical, and quality solutions for life science companies, with expertise across device and therapeutic development pathways including IDE, 510(k), IND, NDA, and BLA submissions.
QPSQPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
Raptim ResearchBioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials.
ReechPharma, LLCReechPharma specializes in customized formulation development and drug delivery systems for preclinical and clinical stages, supporting biotech and pharma companies with formulation research, analytical services, and GMP manufacturing.
SMO India Clinical Research Pvt LtdCDSCO-registered CRO with 25+ years of clinical trial experience across Phase I–IV studies in India. Specializes in site management, clinical operations, and regulatory affairs across diverse therapeutic areas.
SPRIM PROClinical trial and strategic consulting CRO offering innovation-enabled trial solutions, digital training, patient engagement programs, and regulatory consulting across multiple therapeutic areas including oncology, CNS, cardiovascular, and rare disease.
Sacura GmbHSacura specializes in clinical trial management and regulatory support for biotech and pharma companies, with expertise in complex international studies and late-stage preclinical-to-market development planning.
SanaClisGlobal full-service CRO founded in 2000, offering end-to-end clinical trial support across all phases with integrated clinical supply chain management, logistics, and strategic sourcing capabilities.
SciQuus OncologyFull-service CRO specializing in oncology clinical trials, from preclinical IND-enabling studies through Phase I–III trial management, with expertise in First-in-Human studies for new cancer therapies.
Signant HealthClinical trial technology and services provider with 30 years of experience supporting thousands of trials and 25% of novel drug approvals (FDA/EMA, 2021–2024). Offers eClinical solutions, protocol guidance from 50+ in-house scientists and clinicians, and global operational scale.
Simbec-OrionFull-service CRO delivering clinical trial management across early to late phases, with specialist expertise in rare diseases and oncology.
SofpromedFull-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.
Syneos HealthGlobal CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
TFS HealthScienceGlobal mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
The Micron GroupGlobal CRO delivering clinical trial management, regulatory consultancy, data management, and medical writing for biotech, pharma, and medical device companies across Phase I–IV studies and real-world evidence programs.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
TruTechnologiesTruTechnologies delivers live data capture at the point of care for clinical trials, enabling sponsors to detect issues and resolve deviations in real time across 3,300+ sites in 60 countries.
Veeda LifesciencesVeeda Lifesciences is a contract research organization offering preclinical R&D, BA/BE and bioanalytical studies, and Phase I–IV clinical trials for innovative, biosimilar, and generic drugs. Its capabilities cover both small and large molecules, including clinical bioanalysis and real-world evidence.
Markdown mirror: /services/phase-1-clinical-trials.md